The Latest
-
Olympus, EndoRobotics forge distribution pact
The deal to distribute EndoRobotics’ endoscopic robotic devices for gastroenterology follows Olympus’ agreement to co-launch Swan EndoSurgical, a startup developing a robotic GI platform.
-
Mobia Medical plans IPO
The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each.
-
Top medtech executive moves in 2026
Hologic, Teleflex, Grail and others are welcoming new CEOs, while STAAR Surgical is searching for its next leader. Read MedTech Dive’s roundup for all the details.
-
Abbott gets FDA nod, CE mark for AI-enabled imaging device
The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.
-
Insulet starts study of closed loop insulin delivery system
Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.
-
Stryker cyberattack ‘meaningfully’ impacted Q1
CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.
-
Meet 7 medtech companies redefining surgical robotics
Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech Dive's series of profiles.
Updated May 1, 2026 -
Aidoc raises $150M to advance clinical AI foundation model
The company wants AI to support all complex diagnostic decisions by 2030 to prevent diagnostic errors and delays.
-
Teleflex hires Jason Weidman as CEO
After two decades at Medtronic, Weidman will join Teleflex as the medtech company reshapes its portfolio.
-
Medtronic wins FDA approval for updated mitral replacement valve
Surgeons have performed initial implants of the Mosaic Neo valve at centers across the U.S., as well as the first robotic implantation.
-
FDA advises users of Trividia glucometer to switch to alternatives
The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to other blood glucose meters.
-
Profile
Surgeries are moving to ASCs. Distalmotion wants its robot to drive the shift.
CEO Greg Roche says ambulatory surgery centers have largely lacked access to robots for performing soft tissue procedures, until now.
-
Medtronic secures CE mark for Stealth AXiS surgical system
Receiving the clearance positions Medtronic to launch a product that combines surgical planning, navigation and robotics in Europe.
-
Zimmer Biomet CFO departs for new job
Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.
-
Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg
The private equity group plans to accelerate growth of the acquired business, including by empowering it to engage in M&A.
-
Medtronic reports data breach on corporate IT systems
The medtech company does not expect any material impact on its business or financial results, according to a filing with the Securities and Exchange Commission.
-
J&J starts head-to-head PFA trial against Boston Scientific device
The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.